These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 29172777)
21. Role of urokinase plasminogen activator receptor in thrombospondin 1-mediated tumor cell invasion. Albo D; Berger DH; Rothman VL; Tuszynski GP J Surg Res; 1999 Apr; 82(2):331-8. PubMed ID: 10090848 [TBL] [Abstract][Full Text] [Related]
22. Oestradiol regulation of the components of the plasminogen-plasmin system in MDA-MB-231 human breast cancer cells stably expressing the oestrogen receptor. Levenson AS; Kwaan HC; Svoboda KM; Weiss IM; Sakurai S; Jordan VC Br J Cancer; 1998 Jul; 78(1):88-95. PubMed ID: 9662256 [TBL] [Abstract][Full Text] [Related]
23. Interleukin-1alpha enhances the aggressive behavior of pancreatic cancer cells by regulating the alpha6beta1-integrin and urokinase plasminogen activator receptor expression. Sawai H; Okada Y; Funahashi H; Matsuo Y; Takahashi H; Takeyama H; Manabe T BMC Cell Biol; 2006 Feb; 7():8. PubMed ID: 16504015 [TBL] [Abstract][Full Text] [Related]
24. A hybrid protein comprising ATF domain of pro-UK and VAS, an angiogenesis inhibitor, is a potent candidate for targeted cancer therapy. Sun Q; Xu Q; Dong X; Cao L; Huang X; Hu Q; Hua ZC Int J Cancer; 2008 Aug; 123(4):942-50. PubMed ID: 18528863 [TBL] [Abstract][Full Text] [Related]
25. Thrombospondin-1 and transforming growth factor-beta l promote breast tumor cell invasion through up-regulation of the plasminogen/plasmin system. Albo D; Berger DH; Wang TN; Hu X; Rothman V; Tuszynski GP Surgery; 1997 Aug; 122(2):493-9; discussion 499-500. PubMed ID: 9288157 [TBL] [Abstract][Full Text] [Related]
26. Suppression of growth and cancer-induced angiogenesis of aggressive human breast cancer cells (MDA-MB-231) on the chorioallantoic membrane of developing chicken embryos by E-peptide of pro-IGF-I. Chen MJ; Chiou PP; Lin P; Lin CM; Siri S; Peck K; Chen TT J Cell Biochem; 2007 Aug; 101(5):1316-27. PubMed ID: 17286280 [TBL] [Abstract][Full Text] [Related]
27. siRNA-mediated simultaneous downregulation of uPA and its receptor inhibits angiogenesis and invasiveness triggering apoptosis in breast cancer cells. Subramanian R; Gondi CS; Lakka SS; Jutla A; Rao JS Int J Oncol; 2006 Apr; 28(4):831-9. PubMed ID: 16525631 [TBL] [Abstract][Full Text] [Related]
28. Aloperine inhibits proliferation, migration and invasion and induces apoptosis by blocking the Ras signaling pathway in human breast cancer cells. Tian D; Li Y; Li X; Tian Z Mol Med Rep; 2018 Oct; 18(4):3699-3710. PubMed ID: 30132540 [TBL] [Abstract][Full Text] [Related]
29. [Effect of TCF21 on proliferation, migration and vascular production of breast cancer cells]. Li PW; Wang HY; Xu LL Zhonghua Bing Li Xue Za Zhi; 2019 Apr; 48(4):307-311. PubMed ID: 30955268 [No Abstract] [Full Text] [Related]
30. Validation of a network-based strategy for the optimization of combinatorial target selection in breast cancer therapy: siRNA knockdown of network targets in MDA-MB-231 cells as an in vitro model for inhibition of tumor development. Tilli TM; Carels N; Tuszynski JA; Pasdar M Oncotarget; 2016 Sep; 7(39):63189-63203. PubMed ID: 27527857 [TBL] [Abstract][Full Text] [Related]
31. [Expression of epidermal growth factor-adenovirus E4orf4 fusion protein in tumor cells and its cytotoxicity]. Bu PL; Wang DM; Chen H; Huang BR Ai Zheng; 2005 Jan; 24(1):33-9. PubMed ID: 15642197 [TBL] [Abstract][Full Text] [Related]
32. Inhibitory effect of emodin on migration, invasion and metastasis of human breast cancer MDA-MB-231 cells in vitro and in vivo. Sun Y; Wang X; Zhou Q; Lu Y; Zhang H; Chen Q; Zhao M; Su S Oncol Rep; 2015 Jan; 33(1):338-46. PubMed ID: 25370743 [TBL] [Abstract][Full Text] [Related]
33. MiR-125a-5p inhibits the proliferation and invasion of breast cancer cells and induces apoptosis by targeting GAB2. Wang LB; Feng L; He J; Liu B; Sun JG Math Biosci Eng; 2019 Jul; 16(6):6923-6933. PubMed ID: 31698596 [No Abstract] [Full Text] [Related]
34. Expression and anticancer activity analysis of recombinant human uPA1‑43-melittin. Su M; Chang W; Cui M; Lin Y; Wu S; Xu T Int J Oncol; 2015 Feb; 46(2):619-26. PubMed ID: 25394558 [TBL] [Abstract][Full Text] [Related]
35. Hypoxia-mediated stimulation of carcinoma cell invasiveness via upregulation of urokinase receptor expression. Graham CH; Forsdike J; Fitzgerald CJ; Macdonald-Goodfellow S Int J Cancer; 1999 Feb; 80(4):617-23. PubMed ID: 9935166 [TBL] [Abstract][Full Text] [Related]
36. The very low density lipoprotein receptor regulates urokinase receptor catabolism and breast cancer cell motility in vitro. Webb DJ; Nguyen DH; Sankovic M; Gonias SL J Biol Chem; 1999 Mar; 274(11):7412-20. PubMed ID: 10066806 [TBL] [Abstract][Full Text] [Related]
37. Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer. Li XF; Yan PJ; Shao ZM Oncogene; 2009 Nov; 28(44):3937-48. PubMed ID: 19701247 [TBL] [Abstract][Full Text] [Related]
38. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion. Hildenbrand R; Schaaf A Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473 [TBL] [Abstract][Full Text] [Related]
39. FoxM1 down-regulation leads to inhibition of proliferation, migration and invasion of breast cancer cells through the modulation of extra-cellular matrix degrading factors. Ahmad A; Wang Z; Kong D; Ali S; Li Y; Banerjee S; Ali R; Sarkar FH Breast Cancer Res Treat; 2010 Jul; 122(2):337-46. PubMed ID: 19813088 [TBL] [Abstract][Full Text] [Related]
40. Epsilon-aminocaproic acid prevents high glucose and insulin induced-invasiveness in MDA-MB-231 breast cancer cells, modulating the plasminogen activator system. Viedma-Rodríguez R; Martínez-Hernández MG; Flores-López LA; Baiza-Gutman LA Mol Cell Biochem; 2018 Jan; 437(1-2):65-80. PubMed ID: 28612231 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]